Patient-reported outcome assessment in acute leukemias: Moving beyond the barriers

Cancer. 2018 Jul 15;124(14):3066-3067. doi: 10.1002/cncr.31521. Epub 2018 Apr 30.

Authors

Fabio Efficace¹, Francesco Cottone¹, Francesco Sparano¹, Francesco Lo-Coco²

Affiliations

¹ Data Center and Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases, Rome, Italy.
² Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.

PMID: 29710399
DOI: 10.1002/cncr.31521

No abstract available

Publication types

Letter
Comment

MeSH terms

Acute Disease
Antibodies, Monoclonal, Humanized
Humans
Inotuzumab Ozogamicin
Leukemia*
Patient Reported Outcome Measures
Precursor Cell Lymphoblastic Leukemia-Lymphoma*

Substances

Antibodies, Monoclonal, Humanized
Inotuzumab Ozogamicin